Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
Kinston Medical Specialists
mi
from
Kinston, NC
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
Atlanta Diabetes Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trials of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
North Shore University Health System
mi
from
Evanston, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
Medisphere Medical Research Center
mi
from
Evansville, IN
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
Blue Ridge Medical Research
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
Quality Medical Research Pllc
mi
from
Nashville, TN
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
Health Science Research Center
mi
from
Pratt, KS
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical Associates Research Group
mi
from
San Diego, CA
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
Cotton-O'Neil Clinical Research Center, Digestive Health
mi
from
Topeka, KS
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
Professional Research Network of Kansas
mi
from
Wichita, KS
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
PMG Research of Wilmington
mi
from
Wilmington, NC
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastroenterology Associates of Western Michigan
mi
from
Wyoming, MI
Click here to add this to my saved trials
Heart Failure Clinical Trial
Metabolic Mapping and Cardiac Resynchronization
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Infantile Spasm Clinical Trial
A Study to Assess the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms
Status: Enrolling, Phase III
Updated: 12/31/1969
Beaumont Children's Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Bellaire Dermatology Associates
mi
from
Bellaire, TX
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Massachusetts General Hospital - Clinical Unit for Research Trials in Skin (CURTIS)
mi
from
Boston, MA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
West Houston Dermatology, PA
mi
from
Houston, TX
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Allergy & Asthma Care Center of Southern California
mi
from
Long Beach, CA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Quest Diagnostics (Venipuncture Only)
mi
from
Louisville, KY
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatologic Surgery Specialists, Inc.
mi
from
Macon, GA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Associates of Orlando, LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Somerset Skin Centre
mi
from
Troy, MI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Texas Oncology
mi
from
Austin, TX
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Survivorship Care Plan and Embedded Navigation Tool
Status: Enrolling
Updated: 12/31/1969
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
Status: Enrolling, Phase III
Updated: 12/31/1969
Ashland Bellefonte Cancer Center
mi
from
Ashland, KY
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
Status: Enrolling, Phase III
Updated: 12/31/1969
Christiana Care Health System
mi
from
Newark, DE
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southeastern Regional Medical Center
mi
from
Newnan, GA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Treatment Centers of America Eastern Regional Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Childhood Sleep Promotion Clinical Trial
Mobile Health Sleep and Growth Study 2
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Florida Cancer Specialists
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Oncology Clinical Trial
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwest Georgia Oncology Centers, PC
mi
from
Marietta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Northern Westchester Hospital
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
Oncology Clinical Trial
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Alaska Medical Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM
Status: Enrolling, Phase III
Updated: 12/31/1969
Oceane7 Clinical Research, Llc
mi
from
Miami, FL
Click here to add this to my saved trials
Advanced Non-Small Cell Lung Carcinoma Clinical Trial
A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Regeneron Study Site
mi
from
Bronx, NY
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Episodic Migraine Clinical Trial
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwest Clinical Research Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dermatology and Skin Surgery Center
mi
from
Exton, PA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Connecticut
mi
from
Farmington, CT
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Dawes Fretzin Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
The Indiana Clinical Trials Center, PC
mi
from
Plainfield, IN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
OHSU Center for Health and Healing
mi
from
Portland, OR
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Southern California Dermatology, Inc.
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Meridian Clinical Research, LLC
mi
from
Savannah, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
South Bend Clinic
mi
from
South Bend, IN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Forward Clinical Trials
mi
from
Tampa, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
GWU - Medical Faculty Associates, Inc.
mi
from
Washington DC,
Click here to add this to my saved trials
Patient-reported Outcomes Clinical Trial
Using RCT to Increase Completion Rates of the Health Assessment Questionnaire.
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Reproductive Clinical Trial
Virtual Reality in Labor and Delivery for Reduction in Pain
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of ARRY-371797 in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of ARRY-371797 in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of ARRY-371797 in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Innovative Research of West Florida, Inc.
mi
from
Clearwater, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of ARRY-371797 in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Gilbert Medical Center
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of ARRY-371797 in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Heart Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of ARRY-371797 in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
Status: Enrolling, Phase III
Updated: 12/31/1969
CB Flock Research Corporation
mi
from
Mobile, AL
Click here to add this to my saved trials
Progressive Keratoconus Clinical Trial
Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus
Status: Enrolling, Phase III
Updated: 12/31/1969
Bascom Palmer Eye Institute
mi
from
Miami, FL
Click here to add this to my saved trials
Progressive Keratoconus Clinical Trial
Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus
Status: Enrolling, Phase III
Updated: 12/31/1969
UPMC Eye Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Progressive Keratoconus Clinical Trial
Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus
Status: Enrolling, Phase III
Updated: 12/31/1969
Vance Thompson Vision
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immunotherapy Study of BMS-986299 Alone and in Combination With Nivolumab and Ipilimumab in Participants With Solid Cancers That Have Spread or Cannot be Removed
Status: Enrolling, Phase I
Updated: 12/31/1969
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Luke's Hospital, Anderson Campus
mi
from
Easton, PA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Florida Health Cancer Center at Orlando Health
mi
from
Orlando, FL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging
Status: Enrolling
Updated: 12/31/1969
VA Portland Health Care System, Portland, OR
mi
from
Portland, OR
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging
Status: Enrolling
Updated: 12/31/1969
VA Puget Sound Health Care System Seattle Division, Seattle, WA
mi
from
Seattle, WA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging
Status: Enrolling
Updated: 12/31/1969
Syracuse VA Medical Center, Syracuse, NY
mi
from
Syracuse, NY
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging
Status: Enrolling
Updated: 12/31/1969
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Bakersfield, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Berkley, MI
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Bronx, NY
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Greenville, NC
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Lynchburg, VA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Savannah, GA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials